|
24th Pharmaceutical & Medical Device Ethics & Compliance Congress Features OIG Chief Counsel Robert DeConti, JD & OIG Senior Counsel Mary Riordan, JD
|
- A Hybrid Onsite Conference and Internet Event
- Sponsored by Pharmaceutical Compliance Forum
- Media Partners: Policy & Medicine Compliance Update
- October 25-27, 2023
- Gaylord National Resort & Convention Center
- National Harbor, MD
- www.PharmaCongress.com
PRESS RELEASE
Phone: 800-503-7419
Email: reginfo@hcconferences.com
Website: www.PharmaCongress.com |
|
PRESENTATION PROPOSALS FOR PRIORITY CONSIDERATION
|
- Click Here to submit -
The first round of Speaker Presentation Proposals for priority consideration is due no later than Friday, March 31.
|
|
|
|
FEATURING KEYNOTE ADDRESS BY
|
Robert K. DeConti, JD
Chief Counsel to the Inspector General, Office of Counsel to the Inspector General, Office of the Inspector General, US Department of Health and Human Services, Washington, DC |
Mary E. Riordan, JD
Senior Counsel, Office of Counsel to the Inspector General, Office of the Inspector General, US Department of Health and Human Services, Washington, DC
|
|
WASHINGTON, DC USA -- PHARMA UPDATE NEWS SERVICE™ -- MARCH 15, 2023: The Pharmaceutical Compliance Forum (PCF) executive committee is pleased to announce that the Twenty-Fourth Pharmaceutical & Medical Device Ethics and Compliance Congress will be held at the Gaylord National Resort & Convention Center, National Harbor, MD.
|
|
FEATURED FACULTY
|
Eric Bolesh
Chief Operating Officer, Cutting Edge Information, Research Triangle Park, NC |
Greg Demske, JD
Partner, Goodwin Procter LLP; Former Chief Counsel, HHS Office of Inspector General, Washington, DC |
J. Mark Farrar, CPA, CFE, CFF, MSJ, CIPP/US
Managing Director, Epsilon Life Sciences LLC, Atlanta, GA
|
Gary F. Giampetruzzi, JD
Partner, Litigation Department and Global Chair Life Sciences Department, Paul Hastings; Former Vice President and Assistant General Counsel, Head of Government Investigations, Pfizer Inc., New York, NY |
Michael K. Loucks, JD
Partner, Skadden, Arps, Slate, Meagher & Flom LLP; Former Acting US Attorney, Massachusetts, US Department of Justice, Boston, MA |
Nikki Reeves, JD
Partner & Co-chair, Life Sciences and Healthcare Industry Group, King & Spalding, Washington, DC
|
Jeff Rosenbaum, MBA
Partner and Co-founder, Dovetail Consulting Group, Boston, MA |
Julie Ritchie Wagner, JD
Senior Assistant General Counsel, PhRMA; Former Senior Counsel, HHS Office of Counsel to the Inspector General, Washington, DC
|
|
|
PCF EXECUTIVE COMMITTEE
|
Joe Zimmerman
Senior Vice President, Chief Compliance Officer, SpringWorks Therapeutics
(PCF Chair) |
Christie Camelio
Chief Compliance and Risk Officer, EQRx |
Jill Dailey, JD
Vice President & Chief Compliance Officer, Incyte
|
Cheryl Lee, MBA
Vice President, Head of Major Markets Compliance & Ethics, Bristol Myers Squibb |
Joshua Marks, JD
Global Head of Ethics & Compliance Program and Governance, Takeda Pharmaceuticals |
Donna White, CCEP
Vice President, Compliance Officer, Chiesi
|
|
|
MEDICAL DEVICE STEERING COMMITTEE CO CHAIRS
|
Sujata Dayal, JD
Vice President & Global Chief Compliance Officer, Medline Industries, Inc. |
Tara Shewchuk, JD
Chief Ethics & Compliance Officer, Medtronic |
Daniel Spicehandler, JD
Vice President Compliance, Commercial Divisions, Stryker
|
|
|
FEATURING THE PHARMA CONGRESS ADVANCED VIRTUAL STREAMING PLATFORM
|
|
|
PURCHASE ACCESS TO THE 2022 PHARMA CONGRESS ARCHIVE
|
|
|
|
|
|
SPONSORED BY
|
|
|
PRODUCED BY
|
|
|
GRANTORS
|
|
SILVER
|
|
|
BRONZE
|
|
|
EXHIBITOR
|
|
|
|
CONGRESS EXHIBIT & SPONSORSHIP INFORMATION
|
|
For sponsorship and exhibit information contact Suzanne Tyler, Exhibit Manager, at (206) 244-4861 phone, (206) 319-5303 fax, or exhibits@hcconferences.com.
|
|
FOR E-MAIL ADDRESS CHANGE, ADD OR DELETE REQUESTS
|
For changes or additions, please email your request to: listmgr@PharmaUpdateNewsService.com.
For removal of your e-mail address, please click the link below for "SafeUnsubscribe" to automatically remove your address from the list.
|
|
|
